We are currently enrolling healthy adults for a research study at the Johns Hopkins Bayview Medical Center. THIS IS NOT A TREATMENT STUDY. The purpose of this study is to learn more about the effects of an oral cannabigerol (CBG). CBG is a minor cannabinoid commonly found in cannabis (marijuana) and hemp plants.

  Study participation involves completing 1 screening visit that lasts about 2 hours and 5 drug administration visits that each last about 8 hours. During the screening phase, you will complete surveys and interviews, have laboratory tests and a physical examination to determine your study eligibility.

  If you are eligible and elect to participate, you can earn up to $1,830 for completing all portions of the study.